Vaccination with TA-CIN/GPI-0100 induced a neutralizing antibody response against HPV16, whereas TA-CIN alone or GPI-0100 did not trigger a detectable (titer ≥50) neutralizing antibody response against HPV16 (Fig. 2E). This evidence concerns the gene GPI and cervical squamous intraepithelial neoplasia.